Literature DB >> 19416158

Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors.

Pierre De Meyts1, Lisbeth Gauguin, Angela Manegold Svendsen, Mazen Sarhan, Louise Knudsen, Jane Nøhr, Vladislav V Kiselyov.   

Abstract

The insulin/relaxin superfamily of peptide hormones comprises 10 members in humans. The three members of the insulin-related subgroup bind to receptor tyrosine kinases (RTKs), while four of the seven members of the relaxin-like subgroup are now known to bind to G-protein-coupled receptors (GPCRs), the so-called relaxin family peptide receptors (RXFPs). Both systems have a long evolutionary history and play a critical role in fundamental biological processes, such as metabolism, growth, survival and longevity, and reproduction. The structural biology and ligand-binding kinetics of the insulin and insulin-like growth factor I receptors have been studied in great detail, culminating in the recent crystal structure of the insulin receptor extracellular domain. Some of the fundamental properties of these receptors, including constitutive dimerization and negative cooperativity, have recently been shown to extend to other RTKs and GPCRs, including RXFPs, confirming kinetic observations made over 30 years ago.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416158     DOI: 10.1111/j.1749-6632.2009.03837.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

Review 2.  Cardiovascular effects of relaxin: from basic science to clinical therapy.

Authors:  Xiao-Jun Du; Ross A D Bathgate; Chrishan S Samuel; Anthony M Dart; Roger J Summers
Journal:  Nat Rev Cardiol       Date:  2009-11-24       Impact factor: 32.419

3.  'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.

Authors:  Georges Vauquelin; David Hall; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 4.  Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study.

Authors:  Ming-Liang He; Ying Chen; Quan Chen; Yaqing He; Jing Zhao; Jun Wang; Huanming Yang; Hsiang-Fu Kung
Journal:  Am J Cancer Res       Date:  2011-03-30       Impact factor: 6.166

6.  MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling.

Authors:  Tracy J Dixon-Salazar; Lawrence Fourgeaud; Carolyn M Tyler; Julianna R Poole; Joseph J Park; Lisa M Boulanger
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

7.  Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling.

Authors:  Michael D Allen; Susanne Neumann; Marvin C Gershengorn
Journal:  FASEB J       Date:  2011-06-24       Impact factor: 5.191

8.  Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport.

Authors:  Leonid Gaidukov; Andrew R Nager; Shangzhe Xu; Marsha Penman; Monty Krieger
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

9.  Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI.

Authors:  Thomas J F Nieland; Shangzhe Xu; Marsha Penman; Monty Krieger
Journal:  Biochemistry       Date:  2011-02-25       Impact factor: 3.162

10.  Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).

Authors:  Friedrich Metzger; Waseem Sajid; Stefanie Saenger; Christian Staudenmaier; Chris van der Poel; Bettina Sobottka; Angelika Schuler; Mandy Sawitzky; Raphael Poirier; Dietrich Tuerck; Eginhard Schick; Andreas Schaubmar; Friederike Hesse; Kurt Amrein; Hansruedi Loetscher; Gordon S Lynch; Andreas Hoeflich; Pierre De Meyts; Hans-Joachim Schoenfeld
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.